Loading [a11y]/accessibility-menu.js
Identifying Factors for the Effectiveness of Treatment of Heart Failure: A Registry Study | IEEE Conference Publication | IEEE Xplore

Identifying Factors for the Effectiveness of Treatment of Heart Failure: A Registry Study


Abstract:

An administrative health register containing health care data for over 2 million patients will be used to search for factors that can affect the treatment of heart failur...Show More

Abstract:

An administrative health register containing health care data for over 2 million patients will be used to search for factors that can affect the treatment of heart failure. In the study, we will measure the effects of employed treatment for various groups of heart failure patients, using different measures of effectiveness. Significant deviations in effectiveness of treatments of the various patient groups will be reported and factors that may help explaining the effect of treatment will be analyzed. Identification of the most important factors that may help explain the observed deviations between the different groups will be derived through generation of predictive models, for which variable importance can be calculated. The findings may affect recommended treatments as well as highlighting deviations from national guidelines.
Date of Conference: 20-24 June 2016
Date Added to IEEE Xplore: 18 August 2016
ISBN Information:
Electronic ISSN: 2372-9198
Conference Location: Belfast and Dublin, Ireland

I. Introduction

Heart failure (HF) is a serious medical condition resulting in a considerably increased risk of premature death and decreased quality of life. The prevalence of heart failure in Sweden is around 2% [1]. A majority of the patients are elderly. At the age of 80 or above, the prevalence is more than 10%. Proper medication can substantially improve the conditions for many heart failure patients and is in many cases essential for reducing the risk of premature death. At the same time, prescribing patterns for many older patients are affected by co-morbidity and polypharmacy [2]. In a study by Zarrinkoub and others [1], more than 50% of the patients were of age 80 or above in year 2010.

Contact IEEE to Subscribe

References

References is not available for this document.